About VICARDIA THERAPEUTICS INC
ViCardia Therapeutics, Inc. is a clinical-stage biopharmaceutical company focused on developing novel therapies for heart failure, particularly targeting mitochondrial dysfunction and AMPK activation. Founded in 2017, the company aims to improve the healthspan and lifespan of heart failure patients.
Is this your company?
Claim VICARDIA THERAPEUTICS INC to unlock the federal & state contracts GovIntel's AI has matched to you right now — plus your own scored past-performance, who you're up against, and who's risky to team with.
Claim VICARDIA THERAPEUTICS INC & see your matchesFree to claim. Takes about a minute.
Data compiled from public government sources including SAM.gov, USAspending.gov, and state procurement records. Last verified against federal award records. Inaccurate, or want this page removed? Request a correction or removal.